AVL-292 is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <:0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.
Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us
AVL-292 is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.
Specifications and Purity: 10mM in DMSO
Molecular Formula: C22H22FN5O3
Molecular Weight: 423.44
PubChem CID: 59174488
Isomeric SMILES: COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F
At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.
"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was
presently surprised by their product offering."
LAB DIRECTOR
"We utilized Cenmed's capabilities for a variety of projects around the world. They are a valued partner and supplier."
PHARMACEUTICAL SUPPLY CHAIN LEADER
"The reps are very good at finding products for customers in this period of supply chain issues."
SCOTT BEHMAN
"Your customer service has been excellent and makes me excited about purchasing with Cenmed in the future!!"
PROCUREMENT + BILLING COORDINATOR AT PHARMA.
akash.verma@cenmed.com
(732) 447-1115
